114 related articles for article (PubMed ID: 28216154)
21. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals.
Zhao Y; You W; Zheng J; Chi Y; Tang W; Du R
Clin Transl Oncol; 2016 Nov; 18(11):1123-1130. PubMed ID: 26942921
[TBL] [Abstract][Full Text] [Related]
22. Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo.
Dewangan J; Srivastava S; Mishra S; Divakar A; Kumar S; Rath SK
Biochem Pharmacol; 2019 Jun; 164():326-335. PubMed ID: 31028743
[TBL] [Abstract][Full Text] [Related]
23. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression.
Fang J; Zhou Q; Liu LZ; Xia C; Hu X; Shi X; Jiang BH
Carcinogenesis; 2007 Apr; 28(4):858-64. PubMed ID: 17071632
[TBL] [Abstract][Full Text] [Related]
24. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
[TBL] [Abstract][Full Text] [Related]
25. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
26. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
27. Tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone, exhibits potent antiangiogenic activity in vitro.
Han JM; Kwon HJ; Jung HJ
Int J Oncol; 2016 Oct; 49(4):1497-504. PubMed ID: 27498749
[TBL] [Abstract][Full Text] [Related]
28. Suppression of Akt-HIF-1α signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis.
Choi SW; Lee KS; Lee JH; Kang HJ; Lee MJ; Kim HY; Park KI; Kim SL; Shin HK; Seo WD
BMB Rep; 2016 Sep; 49(9):508-13. PubMed ID: 27439603
[TBL] [Abstract][Full Text] [Related]
29. AECHL-1, a novel triterpenoid, targets tumor neo-vasculature and impairs the endothelial cell cytoskeleton.
Dasgupta A; Sawant MA; Lavhale MS; Krishnapati LS; Ghaskadbi S; Sitasawad SL
Angiogenesis; 2015 Jul; 18(3):283-99. PubMed ID: 25952529
[TBL] [Abstract][Full Text] [Related]
30. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
31. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
Ayalasomayajula SP; Ashton P; Kompella UB
J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway.
Zhang LD; Chen L; Zhang M; Qi HJ; Chen L; Chen HF; Zhong MK; Shi XJ; Li QY
Eur J Pharmacol; 2015 Dec; 769():167-76. PubMed ID: 26586335
[TBL] [Abstract][Full Text] [Related]
33. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
34. The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo.
Kim BS; Park H; Ko SH; Lee WK; Kwon HJ
Biochem Biophys Res Commun; 2011 Sep; 413(2):189-93. PubMed ID: 21888894
[TBL] [Abstract][Full Text] [Related]
35. Chaetoglobosin K inhibits tumor angiogenesis through downregulation of vascular epithelial growth factor-binding hypoxia-inducible factor 1α.
Luo H; Li B; Li Z; Cutler SJ; Rankin GO; Chen YC
Anticancer Drugs; 2013 Aug; 24(7):715-24. PubMed ID: 23695013
[TBL] [Abstract][Full Text] [Related]
36. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis.
Wang CH; Yao H; Chen LN; Jia JF; Wang L; Dai JY; Zheng ZH; Chen ZN; Zhu P
Arthritis Rheum; 2012 Jun; 64(6):1818-27. PubMed ID: 22170561
[TBL] [Abstract][Full Text] [Related]
37. Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application.
Lai PX; Chen CW; Wei SC; Lin TY; Jian HJ; Lai IP; Mao JY; Hsu PH; Lin HJ; Tzou WS; Chen SY; Harroun SG; Lai JY; Huang CC
Biomaterials; 2016 Dec; 109():12-22. PubMed ID: 27639528
[TBL] [Abstract][Full Text] [Related]
38. Indatraline inhibits Rho- and calcium-mediated glioblastoma cell motility and angiogenesis.
Heo JC; Jung TH; Jung DY; Park WK; Cho H
Biochem Biophys Res Commun; 2014 Jan; 443(2):749-55. PubMed ID: 24333442
[TBL] [Abstract][Full Text] [Related]
39. Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species.
Lee B; Kim KH; Jung HJ; Kwon HJ
Biochem Biophys Res Commun; 2012 Apr; 421(1):76-80. PubMed ID: 22483751
[TBL] [Abstract][Full Text] [Related]
40. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
